Related Experiment Videos
[Chronic glaucoma treated by trabeculoretraction. Medium-term study of perimetric changes].
F Prost1, J P Lebrere, J Royer
1Clinique Ophtalmologique, CHU Jean-Minjoz, Besançon.
Journal Francais D'Ophtalmologie
|January 1, 1987
Summary
Argon laser trabeculoplasty effectively stabilizes or reduces visual field loss in glaucoma patients. This treatment maintained positive results for one year without altering initial medication regimens.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Laser Therapy
Context:
- Glaucoma is a leading cause of irreversible blindness.
- Visual field defects are a primary indicator of glaucoma progression.
- Argon laser trabeculoplasty is a common surgical intervention for glaucoma management.
Purpose:
- To evaluate the long-term efficacy of argon laser trabeculoplasty in managing glaucomatous visual field defects.
- To assess the stability of visual field improvements over a one-year follow-up period.
- To determine if treatment modifications or medication changes are necessary to maintain therapeutic effects.
Summary:
- Thirty-seven eyes with glaucoma underwent a staged argon laser trabeculoplasty procedure.
- Visual fields were monitored using the Octopus 2000 automatic perimeter.
- Over 85% of eyes demonstrated stabilized or decreased visual field loss by three months and maintained these results at one year, irrespective of initial medication.
Impact:
- Argon laser trabeculoplasty provides sustained visual field stabilization in glaucoma patients.
- The procedure offers a potentially long-term treatment option without requiring immediate medication adjustments.
- Findings support the continued use of argon laser trabeculoplasty as a viable glaucoma treatment strategy.